QUADRANT CAPITAL GROUP LLC

Position in LFCR — Lifecore Biomedical, Inc. \De\

CIK 1650717 CINCINNATI, OH

Position in LFCR

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$6,242

-$9,242 QoQ

Shares Held

1,678

-11.4% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

QUADRANT CAPITAL GROUP LLC holds $18,364,187 across 30 Drug Manufacturers - Specialty & Generic names. LFCR ranks #22 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RDY	Dr Reddys Laboratories Ltd	489,799	$6,783,716
2	TAK	Takeda Pharmaceutical Co Ltd	127,505	$2,361,392
3	ZTS	Zoetis Inc.	17,457	$2,063,591
4	HLN	Haleon plc	118,327	$1,184,453
5	NBIX	Neurocrine Biosciences Inc	7,689	$1,012,948
6	VTRS	Viatris Inc	70,339	$950,279
7	TEVA	Teva Pharmaceutical Industries Ltd	24,340	$733,120
8	LNTH	Lantheus Holdings, Inc.	7,890	$598,456

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,242	1,678	-11.4%	Shares	Sole	2026-05-13
2025-12-31	$15,484	1,893	-1.9%	Shares	Sole	2026-02-13
2025-09-30	$14,204	1,930	-4.6%	Shares	Sole	2025-11-13
2025-03-31	$14,241	2,023	-3.0%	Shares	Sole	2025-05-13
2024-12-31	$15,498	2,086	0.0%	Shares	Sole	2025-02-13
2024-09-30	$10,283	2,086	-13.7%	Shares	Sole	2024-11-12
2024-06-30	$12,394	2,416	0.0%	Shares	Sole	2024-08-12
2024-03-31	$12,828	2,416	0.0%	Shares	Sole	2024-05-15
2023-12-31	$14,955	2,416	0.0%	Shares	Sole	2024-02-08
2023-09-30	$18,240	2,416	0.0%	Shares	Sole	2023-11-14
2023-06-30	$23,362	2,416	0.0%	Shares	Sole	2023-08-10
2023-03-31	$9,132	2,416	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.